Foster & Motley Inc. Acquires 1,730 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Foster & Motley Inc. increased its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 13.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,569 shares of the aerospace company’s stock after purchasing an additional 1,730 shares during the quarter. Foster & Motley Inc.’s holdings in Leidos were worth $1,577,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. International Assets Investment Management LLC purchased a new stake in Leidos during the fourth quarter valued at $18,976,000. Raymond James & Associates increased its position in Leidos by 18.6% during the fourth quarter. Raymond James & Associates now owns 245,665 shares of the aerospace company’s stock valued at $26,591,000 after acquiring an additional 38,496 shares during the last quarter. Northern Trust Corp increased its position in Leidos by 7.8% during the third quarter. Northern Trust Corp now owns 1,143,664 shares of the aerospace company’s stock valued at $105,400,000 after acquiring an additional 82,447 shares during the last quarter. O Shaughnessy Asset Management LLC increased its position in Leidos by 134.9% during the third quarter. O Shaughnessy Asset Management LLC now owns 14,114 shares of the aerospace company’s stock valued at $1,301,000 after acquiring an additional 8,106 shares during the last quarter. Finally, Creative Planning increased its position in Leidos by 15.6% during the third quarter. Creative Planning now owns 95,319 shares of the aerospace company’s stock valued at $8,785,000 after acquiring an additional 12,839 shares during the last quarter. 76.12% of the stock is owned by institutional investors.

Leidos Price Performance

Shares of Leidos stock opened at $128.77 on Wednesday. The stock has a 50 day moving average of $127.16 and a 200 day moving average of $113.22. Leidos Holdings, Inc. has a 12 month low of $76.58 and a 12 month high of $131.50. The firm has a market cap of $17.40 billion, a PE ratio of 90.68, a PEG ratio of 1.74 and a beta of 0.70. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 1.10.

Leidos (NYSE:LDOS) last announced its quarterly earnings results on Tuesday, February 13th. The aerospace company reported $1.99 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.25. The company had revenue of $3.98 billion during the quarter, compared to analyst estimates of $3.81 billion. Leidos had a return on equity of 22.92% and a net margin of 1.29%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.83 earnings per share. On average, research analysts expect that Leidos Holdings, Inc. will post 7.77 EPS for the current fiscal year.

Leidos Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Friday, March 15th were paid a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.18%. The ex-dividend date was Thursday, March 14th. Leidos’s payout ratio is 107.04%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Robert W. Baird upped their price objective on Leidos from $133.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 14th. StockNews.com upgraded Leidos from a “buy” rating to a “strong-buy” rating in a research report on Thursday, April 18th. Barclays upgraded Leidos from an “equal weight” rating to an “overweight” rating in a research report on Friday, January 5th. Royal Bank of Canada upped their price target on Leidos from $105.00 to $120.00 and gave the stock a “sector perform” rating in a research report on Wednesday, February 14th. Finally, Wells Fargo & Company upped their price target on Leidos from $137.00 to $147.00 and gave the stock an “overweight” rating in a research report on Thursday, April 4th. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Leidos has a consensus rating of “Moderate Buy” and an average price target of $132.42.

Insider Activity

In related news, Director David G. Fubini sold 7,874 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the sale, the director now directly owns 14,696 shares of the company’s stock, valued at approximately $1,879,471.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director David G. Fubini sold 7,874 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the sale, the director now directly owns 14,696 shares of the company’s stock, valued at approximately $1,879,471.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gary Stephen May sold 2,745 shares of Leidos stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total value of $341,725.05. Following the sale, the director now directly owns 11,352 shares of the company’s stock, valued at $1,413,210.48. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.